Reverse hybrid and concomitant therapies are equivalent in efficacy for the first‐line treatment of H. pylori infection

Title
Reverse hybrid and concomitant therapies are equivalent in efficacy for the first‐line treatment of H. pylori infection
Authors
Keywords
-
Journal
Publisher
Wiley
Online
2020-03-13
DOI
10.1111/jgh.15034

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started